Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.

AB Science SA (Euronext - FR0010557264 - AB) today reports its revenues for the year 2024 and provides an update on its activities. CLINICAL DEVELOPMENT KEY EVENTS DURING THE YEAR 2024 AND SINCE ...

At least 10 people in the U.S. have been sickened in a listeria outbreak linked to ready-to-eat food products, and a producer ...

Donald Trump has recently made a range of nominations/appointments in the US health sector. They will influence conventional and so-called alternative medicine (SCAM) in the US and beyond. It ...